Simon Lester
Katherine Tai Comments on U.S.-China Relationship, Tariffs on China, IPEF
At an event hosted by the Milken Institute on Monday, U.S. Trade Representative Katherine Tai responded to questions related to the U.S.-China trade relationship in general, and on the U.S. Section 301 tariffs on China in the context of concerns about inflation. She also talked about
USTR Provides Details on Upcoming Review of China Section 301 Tariffs
As we wrote in March, in the coming months, the Office of the U.S. Trade Representative (USTR) will conduct a review of the Section 301 tariffs the United States is currently imposing on China.
NZ China Council Report Discusses NZ-China Trade and Business Relationship
A New Zealand organization has issued a new report on the New Zealand-China economic relationship, examining current trade flows as well as the risks of disruption.
Republican Senators Urge CFIUS Review of Chinese Acquisition of U.S. Semiconductor Company
Last week, five Republican Senators sent a letter to U.S. Department of Treasury Secretary Janet Yellen urging the Department to conduct a Committee on Foreign Investment in the United States (CFIUS) review of Chinese-funded Alphawave IP Group’s intent to acquire U.S.-based semiconductor IP developer OpenFive,
Republican Senators Introduce Bill on SEC Requiring Reporting of Supply Chains Linked to Forced Labor
Six Republican Senators have introduced legislation that would "require the Securities and Exchange Commission to require reporting of sourcing and due diligence activities of companies involving supply chains of products that are imported into the United States that are directly linked to products utilizing forced labor from Xinjiang, China.
U.S. Ambassador to China Comments on U.S.-China Relations and Agriculture Trade
At the recent U.S. – China High Level Agricultural Dialogue in Des Moines, Iowa, U.S. Ambassador to China Nicholas Burns offered his thoughts on U.S.-China relations broadly and on agriculture trade specifically.
Germany Blocks Chinese Takeover of German Medical Company for Health Protection Reasons
The German government has blocked the takeover of a German medical device company by a Chinese company on the basis of public security and health protection.